封面
市场调查报告书
商品编码
1553945

拉伸治疗市场规模、份额、趋势分析报告:依治疗方法、地区、细分市场预测,2024-2030

Stretch Marks Treatment Market Size, Share & Trends Analysis Report By Treatment (Topical Products, Laser, Microdermabrasion, Oils & Serums), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

拉伸治疗市场成长与趋势:

根据Grand View Research, Inc.最新报告,预计到2030年,全球拉伸治疗市场规模将达到5.2913亿美元,2024年至2030年复合年增长率为9.0%。

女性对妊娠期拉伸治疗的认识不断提高,这是成长的主要动力。此外,青少年拉伸的盛行率预计不断上升,将刺激对其治疗的需求。

北美拥有大量肥胖人口,这是该地区市场的主要动力。这是参与者扩大消费者目标并加强市场影响力的机会。此外,该地区主要参与者的增加也是一个竞争因素,对拉伸治疗市场有正面影响。

越来越多的线上入口网站销售治疗拉伸的局部产品,这对玩家来说也是一个机会。因此,主要参与者可以透过这些线上入口网站增加销售额并扩大产品系列。此外,消费者对外用产品的偏好正在增加需求并影响市场。

新产品发布数量的增加以及合作伙伴关係和创新等成长策略的采用是市场趋势。亚太地区的经济成长和消费者消费能力的提高也对市场成长产生正面影响。

拉伸治疗市场报告亮点

  • 由于怀孕、肥胖、生双胞胎或大婴儿、体重快速减轻或增加等引起的拉伸病例不断增加,局部产品已成为主要细分市场。
  • 由于需求旺盛、消费者可支配收入增加以及乳霜促销力度加大,销量增加,预计面霜细分市场在预测期内将出现显着增长。
  • 飞梭雷射领域预计将在预测期内显着增长,因为它是一种改善肤色、减少常见老化征兆和增强皮肤纹理的产品。
  • 脉衝晶粒雷射领域也在显着发展,因为患者的安全得到了完全的保证,不需要麻醉,因为机器在发射脉衝之前会产生冷喷雾,而且我在做的时候没有疼痛感。
  • 由于可支配收入的增加、生活方式的改变以及网路购物网站的出现,亚太地区成为拉伸治疗市场的主导部分。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球拉伸治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 拉伸治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章拉伸治疗市场:按治疗分类的估计和趋势分析

  • 拉伸治疗市场:治疗仪表板
  • 拉伸治疗市场:治疗变化分析
  • 2018-2030 年拉伸治疗市场规模及预测与趋势分析(依治疗方式)
  • 局部产品
  • 雷射
  • 微晶换肤

第五章拉伸治疗市场:按国家和治疗区域进行的估计和趋势分析。

  • 全球拉伸治疗市场:区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第六章 竞争状况

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Alliance Pharma PLC
    • Basq Skincare
    • Clarins Group
    • Candela Corporation
    • Dermaclara Inc.
    • ET Browne Drug Co. Inc.(Palmers)
    • Helix BioMedix Inc.
    • HRA Pharma
    • Laboratoires Expanscience
    • Union Swiss(Pty)Ltd
    • Weleda AG Source
Product Code: GVR-2-68038-977-7

Stretch Marks Treatment Market Growth & Trends:

The global stretch marks treatment market size is expected to reach USD 529.13 million by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness among women regarding the treating stretch marks caused during pregnancy is significantly driving the growth. Also, the growing prevalence of stretch marks in adolescents and teenagers is predicted to fuel the demand for their treatment.

High number of obese population in North America is majorly driving the market in the region. This is an opportunity for the players for expanding their consumer target and strengthening their market presence. Moreover, the increasing number of key players in the region is another factor driving the competition, thereby positively influencing the stretch marks treatment market.

Growing number of online portals for the sale of topical products for treating stretch marks is another opportunity for the players. The key players can thus, increase their sale through these online portals and expand their product portfolio. Moreover, consumer preference for topical products is augmenting its demand, thus affecting the market.

Rise in the launch of new products and adoption of growth strategies, such as partnerships and innovations are trending in the market. Growing Asia Pacific economies and rise in spending power of consumers in these regions is also influencing the market growth positively.

Stretch Marks Treatment Market Report Highlights:

  • Topical products is the leading segment owing to increasing cases of stretch marks caused due to pregnancy, obesity, history of delivering twins or large babies, pale skin, sudden weight loss or gain, and others
  • Creams segment is expected to grow considerably during the forecast period owing to increased sales due to high demand, rise in disposable income of consumers, and increased promotion of creams
  • Fractional laser segment is expected to grow substantially over the forecast period, since these products improve the skin tone, reduce the common signs of aging, and enhance the skin texture
  • Pulse-dye lasers domain is also growing significantly due to completely safety assurance for the patients, no need of anesthesia since the machine produces cold spray just before pulsing, eliminating the pain sensation
  • Asia Pacific is the dominant segment in the stretch marks treatment market owing to increasing disposable income, changing lifestyle, and emerging online shopping portals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Segment
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Stretch Marks Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of obesity globally
      • 3.2.1.2. Rising number of pregnancies and concerns about stretch marks
      • 3.2.1.3. Advancements in treatment technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of the advanced treatment
      • 3.2.2.2. Risk of side effects and complications
  • 3.3. Stretch Marks Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Stretch Marks Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Stretch Marks Treatment Market: Treatment Dashboard
  • 4.2. Stretch Marks Treatment Market: Treatment Movement Analysis
  • 4.3. Stretch Marks Treatment Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Topical Products
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Creams
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Oils & Serums
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Lotions
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Laser
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Fractional Laser
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Pulse-Dye Laser
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1 Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Microdermabrasion
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Stretch Marks Treatment Market: Regional Estimates & Trend Analysis by Country, Treatment.

  • 5.1. Global Stretch Marks Treatment Market: Regional Dashboard
  • 5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Regulatory framework/ reimbursement structure
      • 5.3.4.3. Competitive scenario
      • 5.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Alliance Pharma PLC
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Basq Skincare
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Clarins Group
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Candela Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Dermaclara Inc.
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. E.T. Browne Drug Co. Inc. (Palmers)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Helix BioMedix Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. HRA Pharma
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Laboratoires Expanscience
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Union Swiss (Pty) Ltd
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. Weleda AG Source
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global stretch marks treatment market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7 U.S stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 Mexico stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Europe stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 UK stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Germany stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 France stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Italy stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Spain stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Denmark stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18 Sweden stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Norway stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 Japan stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 China stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 India stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Australia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 Thailand stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 South Korea stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Latin America stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 Brazil stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Argentina stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 MEA stretch marks treatment market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 South Africa stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 UAE stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Kuwait stretch marks treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key companies undergoing acquisitions
  • Table 42 Key companies undergoing collaborations
  • Table 43 Key companies launching new types/services
  • Table 44 Key companies undergoing partnerships
  • Table 45 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Stretch marks treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain - based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Stretch marks treatment market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Stretch marks treatment market treatment outlook:
  • Fig. 14 Stretch marks treatment market: reatment movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global creams market, 2018 - 2030 (USD Million)
  • Fig. 17 Global oils & serums market, 2018 - 2030 (USD Million)
  • Fig. 18 Global lotions market, 2018 - 2030 (USD Million)
  • Fig. 19 Global laser market, 2018 - 2030 (USD Million)
  • Fig. 20 Global fractional laser market, 2018 - 2030 (USD Million)
  • Fig. 21 Global pulse - dye laser market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global microdermabrasion market, 2018 - 2030 (USD Million)
  • Fig. 24 Regional market place: Key takeaways
  • Fig. 25 North America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 UK stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 France stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Asia Pacific stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Japan stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 China stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 India stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 Australia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Latin America stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Brazil stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 MEA stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 South Africa stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Saudi Arabia stretch marks treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Market Participant Categorization
  • Fig. 46 Strategy mapping